secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001493152-22-030207
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros Q3 net revenue $2.4M (-7% YoY); net loss widens to $1.3M; sells PDS business
--------------------------------------------------------------------------------

- Net revenue from continuing operations $2.4M, down 7% vs Q3 2021; net loss $1.3M vs $0.8M.
- Adjusted EBITDA loss from continuing operations -$0.3M, improving from -$0.4M in prior year.
- Active Customer Sites grew 18% YoY to a record 1,391; price pull-ahead in Q2 hurt revenue.
- Sold Pathogen Detection Systems (PDS) business; reduces quarterly expenses by ~$300K.
- Cash and equivalents $3.9M at Sept 30, 2022; management targets positive cash flow by mid-2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/0001493152-22-030207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222030207/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-030207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer